Last reviewed · How we verify
NCT04982341
HFNC and Prone Positioning in Awake Patients With Severe COVID-19
trial testing prone position in Hypoxemic Respiratory Failure in 120 participants. Completed in 3 March 2021.
3 March 2021
Quick facts
| Lead sponsor | Hôpital Universitaire Fattouma Bourguiba |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 2 September 2020 |
| Primary completion | 3 March 2021 |
| Estimated completion | 3 March 2021 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- prone position
Conditions studied
- Hypoxemic Respiratory Failure — all drugs for Hypoxemic Respiratory Failure →
Sponsor
Hôpital Universitaire Fattouma Bourguiba
Who can join
Eligibility, any sex, with Hypoxemic Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators evaluate the effects of High-flow nasal cannula (HFNC) in association with prone in patients with Covid-19 severe ARF.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04982341
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of prone position
Trials testing the same drug.
- NCT06061796 — Physiological Study of Prone Position in Acute Respiratory Failure Syndrome · NA · unknown
- NCT06369584 — Prone Position During ECMO in Pediatric Patients With Severe ARDS · NA · recruiting
- NCT05712135 — Investigation of Endotracheal Cuff Pressure Changes According to Different Positions in Neurosurgery Cases · unknown
- NCT05630443 — Effects of Prone Position After Major Abdominal Surgery · NA · recruiting
- NCT05387356 — Evaluation of the Efficiency and Complications of the Consequtive Proning in Covid -19 ICU · unknown
Other recruiting trials for Hypoxemic Respiratory Failure
Currently open trials in the same condition.
- NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
- NCT06521489 — Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients · NA · active not recruiting
- NCT04938167 — Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hyp · NA · active not recruiting
Other Hôpital Universitaire Fattouma Bourguiba trials
Trials by the same sponsor.
- NCT03981081 — Prednisone Reduction in ICU Patients With COPD Exacerbation · Phase 4 · unknown
- NCT04348227 — How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU? · unknown
- NCT04259073 — Does Pregabalin Improve Post-operative Pain After C-section Delivery · NA · completed
- NCT03373552 — Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04982341 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital Universitaire Fattouma Bourguiba
- Last refreshed: 29 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04982341.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing